-+ 0.00%
-+ 0.00%
-+ 0.00%
KPN (ENXTAM:KPN) Stock Faces Margin Squeeze After Q3 Results
Share
Listen to the news

Koninklijke KPN stock closed at €4.33 on Friday, after the market had time to digest fresh Q3 2026 results. On the surface the move looks modest. Underneath, the story is about pressure on profitability, not revenue drama.

The group reported €1,498m in quarterly revenue, yet the spotlight is on a tighter earnings picture because the adjusted EBITDA margin in telecom is a key yardstick for long term cash generation. Traders are reacting to the headline squeeze. Long term holders are more likely weighing what a thinner margin today means for multi year free cash flow and the current valuation gap.

Love the steady revenue at Koninklijke KPN but uneasy about pressure on profitability and cash generation potential? Screen for telecom and infrastructure peers that pair resilient sales with stronger margins and balance sheets using the list of solid balance sheet and fundamentals stocks (202 results).

Q3 2026 Earnings Summary

  • Revenue (Q3 2026 vs. Q3 2025): €1,498m vs. €1,455m (+3.0%)
  • Net Income (Excl. Extra Items, Q3 2026 vs. Q3 2025): €249m vs. €236m (+5.5%)
  • Basic EPS (Q3 2026 vs. Q3 2025): €0.06 vs. €0.06 (flat)
  • Adjusted EBITDA Margin, Telecom (Q3 2026 vs. Q3 2025): 44.8% vs. 46.2% (compression of 140 bps)

Tired of scrolling through dense earnings releases and raw figures for Koninklijke KPN? See the full visual breakdown of its latest valuation picture in the interactive company report for Koninklijke KPN.

ENXTAM:KPN Trailing 12-Month Earnings & Revenue History as at Oct 2026
ENXTAM:KPN Trailing 12-Month Earnings & Revenue History as at Oct 2026

Koninklijke KPN: Fiber, SME And Cost Goals On Trial

For the bullish view on Koninklijke KPN to work, fiber activation, SME momentum and cost discipline all need to reach concrete waypoints, not just sound good in theory.

"The main thing that has to go right is that KPN continues to grow SME and other higher margin services while holding indirect operating costs on a downward path, despite a competitive Dutch broadband market and tight regulation."

Q3 shows SME revenues growing above 8% and Business service revenues returning to growth, which aligns with that ambition. Indirect OpEx is slightly higher in the quarter yet lower year to date, with management reiterating the €100m 2030 savings goal. EBITDA margin compression and higher direct costs indicate that execution is still a work in progress rather than a completed task.

The price and this Narrative do not agree. → Uncover what this Narrative says Koninklijke KPN is actually worth.

Koninklijke KPN Bear Case: B2B Strain Not Fully Eased

Bearish investors worry that Koninklijke KPN cannot offset B2B weakness and legacy drag with fiber and SME strength alone.

"Bearish analysts expect Koninklijke KPN to face ongoing pressure on group service revenue growth as Tailored Solutions and certain LCE activities weigh on reported B2B performance and limit upside from fiber and consumer trends."

Q3 shows Business service revenues back in positive territory, with SME above 8% and LCE up 2.5%, so the unit is not collapsing. Tailored Solutions headwinds are said to fade by end Q3, which counters the fear of a prolonged slump. The missed milestone sits in profitability. Telecom EBITDA margin compressed 140 bps, showing that better B2B volumes have not yet translated into healthier economics.

Hunt For Mispriced Cash Engines

Koninklijke KPN shows that steady revenue can coincide with pressure on margins. The real opportunity sits in finding stocks that could be undervalued before the market fully joins the dots.

  • Company 1 - 27% below our estimate - taps rising chip and biophotonics equipment orders as manufacturers restart capacity projects and seek higher precision production tools.
  • Company 2 - 21% below our estimate - installs surgical robots and related tools that hospitals adopt to shift complex joint procedures onto a single, data linked platform.
  • Company 3 - 44% below our estimate - builds high acuity hospital capacity and uses AI supported operations to push more complex treatments through an existing referral network.

Those are three of them. See every one of the 201 undervalued companies on it →

Disclaimer:This article represents the opinion of the author only. It does not represent the opinion of Webull, nor should it be viewed as an indication that Webull either agrees with or confirms the truthfulness or accuracy of the information. It should not be considered as investment advice from Webull or anyone else, nor should it be used as the basis of any investment decision.
What's Trending